# TATIN (NCT04148066)

> ctDNA Guided Treatment of Early Resistance to Targeted Treatment

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04148066
- Phase: NA
- Status: COMPLETED
- Sponsor: The Netherlands Cancer Institute
- Conditions: Carcinoma, Non-Small-Cell Lung
- Interventions: ctDNA blood sample
- Enrollment: 104
- Primary outcome: percentage of patients in which a drug resistant clone can be detected with ctDNA

## Indexed commentary on TATIN so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 2 YouTube videos
- 1 post on X

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=tatin-nct04148066